a comparative analysis of Rwanda's performance by Ntegano, Abel
A DISCOURSE ON THE EFFECTIVENESS OF PUBLIC HEALTH EXPENDITURES 
ON HEALTH OUTCOMES IN EAST AFRICA:                                                          
A COMPARATIVE ANALYSIS OF RWANDA`S PERFORMANCE
By
Ntegano Abel
THESIS
Submitted to 
KDI School of Public Policy and Management 
in partial fulfillment of the requirements
for the degree of 
MASTER OF DEVELOPMENT POLICY
2014
A DISCOURSE ON THE EFFECTIVENESS OF PUBLIC HEALTH EXPENDITURES 
ON HEALTH OUTCOMES IN EAST AFRICA:
A COMPARATIVE ANALYSIS OF RWANDA’S PERFORMANCE
By
Ntegano Abel
THESIS
Submitted to
KDI School of Public Policy and Management
in partial fulfillment of the requirements
for the degree of
MASTER OF DEVELOPMENT POLICY 
2014
Professor Kye-Woo Lee

 ABSTRACT
 
A DISCOURSE ON THE EFFECTIVENESS OF PUBLIC HEALTH EXPENDITURES 
ON HEALTH OUTCOMES IN EAST AFRICA:
A COMPARATIVE ANALYIS OF RWANDA’S PERFORMANCE
By
NTEGANO Abel
This study employed the fixed effects regression model to ascertain the effectiveness of 
public health expenditures on health-outcomes in the currently five members East African 
Community, between the period 1995 and 2010. In this study, public health expenditures were 
not statistically significant, in determining the infant mortality and life expectancy rates.                      
This result conforms to Kabir (2008)’s findings. However, urbanization, improved access to 
water and sanitation, coupled with real per capita income were indispensable in clarifying the 
infant mortality rate performance, all registering statistically significant negative signs. 
Real per capita income, urbanization, nutritious food consumption, plus improved access 
to water and sanitation were statistically significant, and positively related to the life expectancy 
rate. The HIV/AIDS prevalence rate was also statistically significant, and negatively related to 
the life expectancy rate.
Owing to Rwanda`s considerable infant mortality rate, as well as low life expectancy rate,
despite its relatively high public health expenditures during the period between 1995 and 2010, 
 the aforementioned significant determinants of health outcomes, were invoked to inform the 
policy prescriptions the East African Community, and Rwanda in particular can adopt to better 
the health status.
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CHAPTER ONE: INTRODUCTION
BACKGROUND
The main purpose of this research is to ascertain the effectiveness of public funds 
expended on the health sector in the East African Community, in improving the health status 
between 1995 and 2010. To this end, Rwanda`s performances in terms of reducing the 
HIV/AIDS prevalence rate, decreasing the infant mortality rate, increasing the life expectancy 
rate, and registering success in treating Tuberculosis are compared to other four East African 
Community countries of Kenya, Uganda, Tanzania and Burundi. Performed data analysis 
suggests that despite Rwanda`s relatively substantial public health expenditures, the infant 
mortality rate was instead high, and the life expectancy rate was the lowest in the region, which 
begs the question why no salutary effects were imposed on the latter health outcomes.
Against this background, this paper by and large seeks to answer the aforementioned 
telling question. Expending money on the health sector is predicated upon the productivity of a 
healthy work-force, with capacity to work smarter, harder, and longer. Albeit “macroeconomists 
acknowledge the contribution of human capital to economic growth, their empirical studies 
define human capital solely in terms of schooling” (Bloom et al 2001). Granting that health`s 
impact on economic growth is as great as schooling’s impact on economic growth, this paper 
submits that sustainable and increased commitment of funds to the health sector can only be 
justified, if it translates into desired health benefits such as low HIV/AIDS prevalence rates, 
longer life expectancy rates, low Malaria death rates, low Infant Mortality Rates, and 
Tuberculosis treatment success. 
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1. PROBLEM STATEMENT
Notwithstanding its large Public Health Expenditures, relative to its East African 
Community counterparts, the infant mortality rate in Rwanda was high and the life expectancy 
rate rather low, in the period between 1995 and 2010. As part of the “United Nation’s 
Millennium Development Goals (MDGs)” targets, it proves very imperative to comprehensively 
understand other mechanisms via which, the latter health outcomes can be bettered, so as to 
improve the quality of life in Rwanda. If channeling huge funds into the health sector alone 
hardly conduces to good health, therefore other viable options such as subsisting on a nutritious 
diet, dwelling in hygienic conditions, etc ought to be explored.
1. STUDY OBJECTIVES 
This paper`s overarching objective, is to take stock of Rwanda`s health outcomes 
performance, given the relatively large financial commitments into its health sector, over the 
period 1995 and 2010. Specifically stated, this study`s overarching objective is to:
 Ascertain the effectiveness of public health expenditures in achieving the desired health 
benefits, for instance reducing infant mortality as well as increasing life expectancy rates.
1.6TUDY SIGNIFICANCE 
 
The study ascertains other determinants of health outcomes in the East African 
Community, besides public health expenditures, with high statistical significance, and thus 
plausibly high policy import that can be implemented by Rwanda. In so doing, the study aims to 
show that public health expenditures, given the country`s low level of economic development, 
should for instance be supplemented by programs geared towards increasing the consumption of 
food high in nutritious value, improving the real income per capita, and urbanization, so as to 
create desired health benefits in an effective and sustainable manner.
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1.6TUDY MOTIVATION
Analyzing the trend of health expenditures and aggregate health indicators constitutes the 
overarching motivation for this study. For instance, preliminary investigations on Rwanda show 
that the trend of public health expenditures was on the rise, but health indicators such as life 
expectancy rates were not rising, or infant mortality rate reducing commensurate with the high 
public health expenditures. Then aspersions are cast on the efficacy of public health expenditures.
Perchance other significant factors explaining variations in health outcomes exist, besides public 
health expenditures, which can inform policy prescriptions in improving the health status in the 
East African Community in general, and Rwanda in particular. 
1.5ESEARCH QUESTIONS AND HYPOTHESIS
The cardinal question sought to be answered by this paper, is whether public expenditures on 
health in the East African Community conduced to desired health benefits. Precisely stated:
 Do health indicators such as the infant mortality and life expectancy rates improve, as
public health expenditures get increased?
 If so, why did Rwanda`s relatively large public health expenditures in the East African 
Community, not translate into reduced infant mortality rates as well as increased life 
expectancy rates?
1.7HE STRUCTURE OF THE PAPER
This paper is structured as follows: After the introduction, in chapter two the existing 
literature is reviewed, the employed analytical methodology and data presented in chapter three,
the related results are discussed in chapter four, coupled with policy implications and conclusive 
remarks in chapter five.
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CHAPTER TWO: LITERATURE REVIEW
 
“There is an extensive literature on health expenditures and their growth in OECD 
countries. However evidence from developing countries is relatively scarce.” (Saksena and Holly 
2011). Indeed researchers such as Bichaka and Gutema (2008), Kaseje (2006), Jaunky and 
Khadaroo (2006) submit that insufficient health-care funding in Africa, frustrates efforts to 
improve health outcomes, for instance infant mortality and life expectancy rates. To this end, this 
study`s overarching purpose is to analyze the success of public health care expenditures on 
health outcomes, in the five East African countries, particularly Rwanda`s performance relative 
to its regional counterparts. Prior to expatiating on the efficacy of public health expenditures in 
perking up the healthiness status, a brief definition of what constitutes national health spending is 
introduced. Finally the factors explaining variations in desired health outcomes, to ascertain 
prevailing controversies in the extant literature are discussed.
It is vitally important to state from the outset that East African Community used to 
include only the three countries of Kenya, Tanzania, and Uganda. 1However, Rwanda and 
Burundi joined the East African Community on June 18, 2007, which essentially implies that this 
study`s definition of what constitutes East African Community, uniquely differs from other 
related papers researching on particular regions in Africa, or Africa as a whole (Anyanwu and 
Erhijakpor 2007 and Okunade 2005).
“Total health care expenditure is generally categorized as public and private health care 
expenditure” (Novignon et al 2012). Public health expenditures include essentially domestic
                                                          
1 Accessed http://www.afrol.com/articles/23097, on the integration of Rwanda and Burundi into the East 
African Community.
5 
 
resources and external funding channeled to all government’s health related activities. 2
Private health expenditures constitute “payments made by the patients at the point of receiving 
medical services” (Saksena and Holly 2011). By and large, some researchers use total health 
expenditures, in their studies germane to health spending and related outcomes (Olaniyan et al 
2013, Anyanwu and Erhijakpor 2007, and Novignon et al 2012). Other researchers employ either 
public or private health care expenditures (Guerriere et al 2008 and Costa-Font and Pons-Novell 
2007). Furthermore, researchers focus on say the OECD member countries, when explaining 
variations in health care outcomes (Or 2000, Jee and Or 1999). Needless to say, related studies 
have been done on Africa as previously indicated in this chapter. 
Using “panel data from 1995 to 2010, covering 44 countries in Sub-Saharan Africa,”
Novignon et al. (2012) ran fixed and random effects regression models to determine the effect of 
total health care expenditures on health outcomes. They explain that basically health outcomes 
comprise “life expectancy, infant mortality, and the death rate”. Researchers in existing literature 
are divided according to health-care expenditures' salutary effect on the latter health-outcomes, 
and health expenditures` lack of statistical insignificance in determining the health status. For 
instance, Bhalotra (2007) used similar specifications in the existing literature, but did not find 
any reductive result of “public health expenditures on infant mortality rate in India.” 3 By 
invoking “cross-sectional data on 98 developing countries, to ascertain the impact of public 
                                                          
2 Novignon et al.: “The effects of public and private health care expenditure on health status in sub-
Saharan Africa: new evidence from panel data analysis”. Health Economics Review 2012, 2.
3 Sonia, Bhalotra. "Spending to Save? State Health Expenditure and Infant Mortality in India." Discussion 
Paper Series IZA DEP, no. 2914, 2007, 4.
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health expenditure on infant mortality” 4, Filmer and Pritchett (1999) found a tenuous and 
statistically insignificant effect of the former on the latter.
On the other hand, by “employing Ordinary Least Square (OLS) and panel data 
techniques on 160 countries,” Issa and Ouattara (2005) showed that a strong negative 
relationship exists between health outlays expenditures and infant mortality rates (IMRs). Gupta 
et al (2002) despite showing the existence of “a negative correlation between public health 
expenditure and child mortality” 5, this relationship was not robust to other model specifications. 
In addition, by invoking a 22-developing country cross-sectional data in 1985, Ravallion et al 
(1993) discovered a beneficial effect of “health expenditures on life expectancy”, albeit income 
had no effect.
 
Central to this study, is that Issa and Ouattara (2005) show that “Alves and Belluzo 
(2005) estimated static and panel data models, using census data from Brazil for the period 1970-
2000 to investigate the determinants of infant mortality rates. The findings of their paper confirm 
that poor child health, in terms of mortality rates in Brazil, can be explained by the levels of 
education, sanitation, and poverty.” Moreover in his study on the “determinants of life 
expectancy in developing countries,” where he employed multiple regression and probit 
frameworks, Kabir (2008) found that “most of the explanatory variables turned out to be 
statistically insignificant, implying that the important socio-economic factors such as income per 
capita, education, public health expenditure, access to safe water, and urbanization cannot always 
be considered to be influential in determining life expectancy in developing countries.” 
                                                          
4 Ibid.; 5.
5 Gupta, S., M. Verhoeven and E. Tiongson. “Public spending on health care and the poor”, Health 
Economics, 2003, 12: 685-96.3.
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In a nutshell, it suffices to say that tenuous salutary effect of public health expenditures 
on health outcomes can plausibly be explained, inter alia, by the existence of other statistically 
significant factors in explaining the variations in say infant mortality and life expectancy.            
The latter cogent possibility forms the most integral part of this study. Precisely stated, if 
Rwanda`s relatively high public health expenditures are not conducing to a reduction in infant 
mortality rates, and an increase in life expectancy. If other significant determinants of health 
outcomes abound besides public health expenditures, then they worth being considered by the 
Rwandan government, in its efforts to improve its country`s health status.
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CHAPTER THREE: MODEL SPECIFICATION AND METHODOLOGY
 
3.1 MODEL SPECIFICATIONS
 
To demonstrate the effectiveness of public health care expenditures in achieving the 
desired health benefits, a panel data fixed effects regression is run using the STATA econometric 
software, for the period between 1995 and 2010; it comprises the currently five East African 
Community countries (i.e. Uganda, Kenya, Tanzania, Burundi and Rwanda). The data employed 
in this study came from the “World Bank`s World Development Indicators database”. 6 The 
standard static model enables the predictor intercepts to represent country effects, it takes the 
basic structure, with “i” denoting each country, whereas “t” represents a period of time as 
follows:
LINFMOit0 1LPHEYit 2LIWAit 3LISAFit 4LFPIit 5LURBit + 6LCLEANit +
7LHIVPREVit + 8LRYCit + 9EDUC2it + it……………….…………………………….… (1)
LLIFEit 0 	
it 2LIWAit 3LISAFit 4LFPIit 5LURBit + 6LCLEANit +
7LHIVPREVit + 8LRYCit + 9EDUC2it +it…………………………................................. (2)
Where:
LINFMO= logarithmic transformation of Infant Mortality Rate.
LLIFE= logarithmic transformation of life expectancy at birth.
LPHEY= logarithmic transformation of “public health expenditures as a share of GDP” (“- sign
in Model 1 and + sign in Model 2”). LPHEY is the main predictor of this study.
                                                          
6 Accessed http://www.data.worldbank.org/indicator.
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LIWA=logarithmic transformation of Improved Access to Water (“- sign in Model 1 and + sign                      
in Model 2”)
LHIVPREV=logarithmic transformation of HIV/AIDS Prevalence Rate (“+ sign in Model 1 and 
– sign in Model 2”)
LISAF = logarithmic transformation of Improved Access to Sanitation Facilities (“- sign in 
Model 1 and + sign in Model 2”)
LFPI = logarithmic transformation of Food Production Index (“- sign in Model 1 and + sign in 
Model 2”)
LCLEAN = Interaction Term of LISAF and LIWA (“-sign in Model 1 and + sign in Model 2”)
LURB= logarithmic transformation of urbanization (“- sign in Model 1 and + sign in Model 2”)
LRYC= logarithmic transformation of Real GDP Per capita (“- sign in Model 1 and + sign in 
Model 2”)
LEDUC2= logarithmic transformation of school enrollment, secondary, female (% gross).                    
(“– sign in Model 1 and + sign in Model 2”) 
it = Error Term
Model 1 seeks to measure public health expenditures (PHEY) effectiveness in reducing 
the infant mortality rate, while Model 2 measures measure public health expenditures (PHEY) 
effectiveness in increasing the life expectancy rate. The expected signs of the controlled 
variables` coefficients are also duly attached, as anticipated in the paper`s third chapter.
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Akin to other researchers in the existing literature on “public health expenditure and 
health outcomes (infant mortality, life expectancy, etc)”, urbanization, “share of public health 
expenditure in GDP”, female education, and “real income per capita” are also controlled for in 
Model 2 (Kabir 2008, Filmer and Pritchett 1999). An interaction term between improved water 
access (LIWA) and improved sanitation access facility (LISAF) is also controlled for in both 
Models to proxy general cleanliness. More so, as per the World Bank, FPI represents the “Food 
production index”, covering “food crops that are considered edible and that contain nutrients;
coffee and tea are excluded because, although edible, they have no nutritive value.” It is used in 
this study to proxy malnutrition. 
3.2 VARIABLES AND DATA DESCRIPTION7
 
1. “Mortality rate, infant (per 1,000 live births)”.
The World Bank defines the “infant mortality rate as the number of infants dying before 
reaching one year of age, per 1,000 live births in a given year.” This is one of “the health 
outcomes” being tested in this study, and as such a dependent variable.
2. “Life expectancy at birth, total (years)”
According to World Bank, “life expectancy at birth indicates the number of years a 
newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay 
the same throughout its life.” It is also one of the health outcomes being tested in this study, and as 
such a dependent variable.
                                                          
7 As indicated in this chapter, this research used the data from “World Bank’s World Development 
Indicators data base”. Therefore, the definitions of variables used are also from the World Bank’s 
description and definitions in order to keep their meanings as defined by the World Bank.
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3. “Health expenditure, public (% of GDP)”
As per the World Bank, “public health expenditure consists of recurrent and capital 
spending from government budgets, external borrowings and grants (including donations from 
international agencies and nongovernmental organizations), and social (or compulsory) health 
insurance funds.” These expenditures can potentially lead to good health outcomes, but their 
effectiveness in doing so, is being investigated in this study. This variable is consistently used in 
the literature (Novignon et al 2012).
4. “Health expenditure, public (% of government expenditure)”
The World Bank also explains that “public health expenditure consists of recurrent and 
capital spending from government budgets, external borrowings and grants (including donations 
from international agencies and nongovernmental organizations), and social (or compulsory) 
health insurance funds.” For any robustness test, this plausible independent variable should exert 
a salutary effect, akin to the aforementioned (Kabir 2008).
5. “Tuberculosis treatment success rate (% of registered cases)”
As per the World Bank, “Tuberculosis treatment success rate is the percentage of new, 
registered smear-positive (infectious) cases that were cured or in which a full course of treatment 
was completed.” This variable`s movement with public health expenditures over the study period 
is graphically illustrated.
6. “Improved water source (% of population with access)”
The World Bank defines “access to an improved water source as the percentage of the 
population using an improved drinking water source. The improved drinking water source 
includes piped water on premises (piped household water connection located inside the user’s 
dwelling, plot or yard), and other improved drinking water sources (public taps or standpipes, 
12 
 
tube wells or boreholes, protected dug wells, protected springs, and rainwater collection).” It is 
expected to reduce the infant mortality rate, by decreasing the incidence of water-borne diseases, 
or to increase the life expectancy rate (Novignon et al 2012 and Kabir 2008).
7. “Improved sanitation facilities (% of population with access)”
According to the World Bank, this variable refers to the “access to improved sanitation 
facilities, shown as the percentage of the population using improved sanitation facilities.                     
The improved sanitation facilities include flush or pour flush (to piped sewer system, septic tank, 
and pit latrine), ventilated improved pit (VIP) latrine, pit latrine with slab, and composting 
toilet.”  It is expected to either reduce the infant mortality rate, or increase the life expectancy 
rate via ensuring the environment is maintained in proper salubrious conditions, free from 
pathogenic organisms (Novignon et al. 2012 and Kabir 2008).
7. “Prevalence of HIV, total (% of population ages 15-49)”
The World Bank defines the “prevalence of HIV as the percentage of people ages 15-49
that are infected with HIV.” Its incidence can potentially increase the infant mortality rate, and 
also decrease the life expectancy rate, especially in cases where early detection is not possible or 
denied by the victim, hence precluding medical treatment (Novignon et al 2012).
9. “Food production index (2004-2006 = 100)”
As per the World Bank, “food production index covers food crops that are considered 
edible and that contain nutrients. Coffee and tea are excluded because, although edible, they have 
no nutritive value.” Consumption of food with high nutritious value can either reduce the infant 
mortality rate, or increase the life expectancy rate. Researchers such as Shaw et al (2005) instead 
used “fruit and vegetable consumption, including fat consumption.”
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10. “Urban population (% of total)”
The World Bank describes “urban population as people living in urban areas, as defined 
by national statistical offices.” It is used in this study as a proxy for urbanization. It is expected 
to increase access to facilities and infrastructure related to health, such as quality hospitals, with 
the adequate number of beds and physicians. Therefore urbanization would reduce the infant 
mortality rate, and also increase life expectancy (Anyanwu and Erhijakpor 2007 and Kabir 2008).
11. “School enrollment, secondary, female (%gross)”
As per the World Bank, “Gross enrolment ratio, Secondary for female is the total female 
enrollment in secondary education, regardless of age, expressed as a percentage of the female 
population of official secondary education age. GER can exceed 100% due to the inclusion of 
over-aged and under-aged students because of early or late school entrance and grade repetition.” 
It can either reduce the infant mortality rate, or increase the life expectancy rate, as awareness of 
pro-good health practices and measures increases (Issa and Ouattara 2005 and Kabir 2008).
12. “GDP per capita (constant 2000 US$)”
According to the World Bank, “GDP per capita is gross domestic product divided by 
midyear population. GDP is the sum of gross value added by all resident producers in the 
economy plus any product taxes and minus any subsidies not included in the value of the 
products. It is calculated without making deductions for depreciation of fabricated assets or for 
depletion and degradation of natural resources. Data are in constant 2005 U.S. dollars.” It 
captures the people’s wealth as well as their capacity to access medical services and facilities, 
which in turn produces desired health outcomes (Novignon et al 2012, and Kabir 2008).        
14 
 
For purposes of clarity and simplicity, a tabular illustration in Table 1 shows the description of 
the data used in this study and their related sources are shown below:
Table 1: Data and their related sources
VARIABLE ACRONYM DESCRIPTION SOURCE
“Mortality rate, infant (per 1,000 live 
births)”
INFMO Dependent Variable WDI
“Life expectancy at birth, total (years)” LIFE Dependent Variable WDI
“Health expenditure, public (% of GDP)” PHEY Independent Variable WDI
“Health expenditure, public (%
of government expenditure)”
PHEGE Independent Variable WDI
“Tuberculosis treatment success rate 
(% of registered cases)”
TTS Independent Variable WDI
“Improved water source (% of population 
with access)”
IWA Independent Variable WDI
“Improved sanitation facilities 
(% of population with access)”
ISAF Independent Variable WDI
“Prevalence of HIV, total (% of population 
ages 15-49)”
HIVPREV Independent Variable WDI
“Improved water source (% of population 
with access) x
Improved sanitation facilities (% of 
population with access)”
CLEAN 
(Interaction term)
Independent Variable WDI
“Food production index (2004-2006 = 
100)”
FPI Independent Variable WDI
“Urban population (% of total)” URB Independent Variable WDI
“School enrollment, secondary, female (% 
gross)”
EDUC Independent Variable WDI
“GDP Per Capita (Constant 2000US$)” RYC Independent Variable WDI
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It suffices to say that central to this study, is its primary focus on public health 
expenditures, as opposed to “out-of-pocket payments”8 (akin to private health expenditures). 
Furthermore, despite the fact that this study seeks to tease out Rwanda`s comparative 
performance, vis-à-vis the other four East African countries, a separate OLS regression to 
capture its unique experience is not run, due to data insufficiency. Nonetheless, bar graphs and 
tabular data analyses, pertaining to country specific mean health-performance indicators are used, 
to ascertain Rwanda`s relative performance.
Regarding robustness of the model specified a Hausman test whose results are shown 
below, so as to choose between either the fixed or random effects model was performed, where 
the null hypothesis is that the preferred model is random effects versus the alternative fixed 
effects. The probability result was found to be statistically significant, rejecting the null 
hypothesis and thus opting for the fixed effects model. “The fixed effects model controls for all
time-invariant differences between the individuals, so that the fixed effects models cannot be 
biased because of time-invariant characteristics” (Kohler et al. 2009).
 
                                                          
8 “Out-of pocket payments are payments made by patients at the point of receiving medical services”
qualifying them as an integral part of national health spending (Saksena and Holly 2011).
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CHAPTER FOUR: RESULTS OF EMPIRICAL ANALYISIS AND 
RELATED DISCUSSION
 
4.1 Descriptive Analysis 
To begin the econometric analysis, a brief descriptive analysis of the data, including the 
correlation matrix is demonstrated in Table 2 below.
Table 2: Descriptive Statistics
PANEL A: SUMMARY STATISTICS 
INFMO LIFE PHEGE PHEY RYC TTS IWA ISAF HIVPREV FPI URB EDUC2 CLEAN
OBS 80 80 80 80 80 80 80 80 80 80 80 80 80
MEAN 79.86 49.78 10.35 3.14 292.06 74.53 59.55 32.85 6.05 90.74 19.053 19.30 2048.57
STD.DEV 21.47 4.84 3.75 2.25 107.28 12.18 10.06 14.37 2.28 17.61 4.84 13.26 1107.154
MIN 41.5 30.47 6.18 1.40 128.30 33 38 8 1.6 49.5 8.29 4.79 432
MAX 138.9 57.38 22.44 10.77 470.58 92 72 55 11.1 137.37 26.28 57.10 3630
PANEL B: CORRELATION MATRIX WITH LOGARITHMIC VARIABLES
 LINFMO LLIFE LPHEGE LPHEY LRYC LTTS LIWA LISAF LHIVPREV LFPI LURB LEDUC2 LCLEAN
LINFMO 1.000
LLIFE -0.866 1.000
LPHEGE -0.330 0.199 1.000
LPHEY -0.062 -0.063 0.722 1.000
LRYC -0.764 0.628 0.058 -0.230 1.000
LTTS -0.535 0.555 0.197 0.268 0.236 1.000
LIWA 0.395 -0.417 0.369 0.489 -0.737 -0.055 1.000
LISAF 0.257 -0.303 0.094 0.449 -0.475 -0.172 0.491 1.000
LHIVPREV -0.113 0.083 -0.377 -0.749 0.612 -0.360 -0.734 -0.533 1.000
LFPI -0.670 0.560 0.377 0.210 0.251 0.330 0.139 0.183 -0.209 1.000
LURB -0.407 0.597 -0.055 -0.022 0.028 0.688 -0.128 -0.328 -0.282 0.289 1.000
LEDUC2 -0.732 0.650 -0.075 -0.046 0.649 0.447 -0.489 0.062 0.109 0.460 0.270 1.000
LCLEAN 0.318 -0.363 0.173 0.505 -0.590 -0.160 0.66 0.976 -0.638 0.191 -0.311 -0.069 1.000
From the aforementioned Table 2 Panel B, it is shown that both LPHEGE an LPHEY are
negatively related to LINFMO. LPHEGE is also positively related to LIFE. LFPI, the proxy for 
nutritive food consumed shows a negative relation to LINFMO and a positive relation to LLIFE 
while LURB exhibits a negative relation to LINFMO and a positive relation to LLIFE.
Secondly, tabular illustrations of countries sampled in this study, including the related 
investigated variable means are exhibited in Table 3. 
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Table 3: Sampled Countries and their Mean Variables (1995-2010) 
COUNTRY INFMO LIFE PHEGE PHEY RYC TTS IWA ISAF HIVPREV FPI URB EDUC2 CLEAN
BURUNDI 97.162 46.969 8.968 3.1476 133.95 77.188 71.688 45.562 3.4 90.489 23.31 11.08 3266
KENYA 63.4125 53.841 7.326 1.786 427.0 80.128 45 29.187 8.05 93.194 20.83 41.74 1319
RWANDA 89.218 47.277 14.605 6.67 257.36 72.531 66 48.875 4.088 90.743 14.867 14.839 3225
TANZANIA 70.218 52.365 10.723 2.327 352.45 81.375 53.813 9.187 7.069 86.212 23.311 14.271 494
UGANDA 79.281 48.451 10.101 1.799 289.57 61.437 61.25 31.437 7.643 93.063 12.944 15.035 1937
EAC 79.852 44.781 10.345 3.145 292.06 74.53 59.55 32.85 6.05 90.74 19.053 19.309 2048
 
From the aforementioned data, Rwanda has the highest mean public health expenditure-
PHEGE (14.605) among the East African Community member countries, above the EAC 
average of 10.345. Rwanda also registered the highest mean PHEY of 6.67, well above the East 
African Community average of 3.14. Second to Burundi in the East African Community region, 
Rwanda has a decent mean improved water access (IWA) of 66, above the EAC average of 59.55, 
while its HIVPREV is the second lowest in East Africa, after Burundi, below the region`s 
average of 6.05. Rwanda`s mean Tuberculosis Treatment Success (TTS) is plausibly above the 
East African Community average (74.53), at 72.531. Rwanda also had the highest improved 
sanitation access facility (ISAF); (48.875) relative to the EAC average of 32.85. Rwanda`s mean 
urbanization (URB) was the second lowest in the East African Community after Uganda`s at 
14.87.
Forming the integral part of this study, Figures 19 and 2 show the movement of the 
desired health benefits with public health expenditures over the study period (1995-2010) in the 
East African Community and Rwanda respectively. The idea here is to illustrate the East African 
Community’s general trend pertaining to say, the Infant Mortality Rate, HIV/AIDS Prevalence 
Rate, Life Expectancy Rate, and Public Health Expenditures (LPHEY and LPHEGE). By and 
large, Infant mortality (LINFMO) for the East African Community is shown to reduce as Public 
                                                          
9 Figure 1 shows a five country East African Community historical evolution, in terms of public health 
expenditures and related outcomes, which comprises Kenya, Tanzania, Uganda, Burundi, and Rwanda.
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Health Expenditures (LPHEY) increases, while for Rwanda`s case in Figure 2 the desired 
reductive effect of LINFMO by LPHEY is not significant, prompting the plausible question 
whether other factors can impose a more telling effect in Rwanda.
Figure 1: Panel health indicators’ trend in the East African Community (1995-2010)
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Figure 2: Health Indicators trend in Rwanda (1995-2010)
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The following scatter-plots show the relative ratios of each country`s health status 
variable to Kenya`s, computed on the basis that 10Kenya`s economy is the strongest in the East 
African Community at an average Real Income Per Capita of 427.00, Rwanda`s 257.37, 
Uganda`s 289.257, Tanzania`s 352.451, Burundi`s 133.957, and the EAC`s 292.069. The latter 
information is “GDP per capita (constant 2000 US$)”, sourced from the “World Development 
Indicators” data-base (WDI), and computed from the study period (1995-2010). Next up are 
scatter plots, coupled with bar graphs from the STATA econometric software.
Figure 3: Mean Infant Mortality Rate and Mean Public Health Expenditures
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Figure 3 above suggests as denoted initially in the paper that despite Rwanda`s relatively 
huge public health expenditures, its infant mortality rate was the second highest in the East 
African Community region, after Burundi, way above the EAC average.
                                                          
10 See Table 3 above.
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This consequently begs the question why public health expenditures (PHEY) between 
1995 and 2010 in Rwanda hardly facilitated a reduction in the infant mortality rate. To partly 
answer the latter question, a fixed effects regression with Infant mortality (LINFMO) as the 
dependent variable is run to explain its variation, while controlling for LPHEY. It is surmised 
that other predictors besides LPHEY may significantly affect LINFMO.
Figure 4: Mean Life Expectancy Rate and Mean Public Health Expenditures.
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Figure 4 above illustrates that Rwanda on average had the lowest mean LIFE in the East 
African Community region, notwithstanding its highest PHEY. Here also a plausible empirical 
question arises why Rwanda`s relatively huge LPHEY did not translate into a lower life 
expectancy rate. With LLIFE as the dependent variable, a fixed effects regression is run, while 
controlling for other variables in the literature, including LPHEY to assess its effectiveness in 
facilitating an increase in life expectancy (LLIFE).
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Figure 5: Mean Tuberculosis Treatment Success rate and Mean Public Health 
Expenditures.
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Figure 5 above demonstrates that Rwanda`s relatively large PHEY in the East African 
Community region, basically corresponded with an increase in Tuberculosis Treatment Success 
(TTS), although Uganda registered the worst relative performance in this regard. Nonetheless, 
the policy implication that can be drawn from this figure is how Kenya, Tanzania and Burundi 
are able to achieve higher TTS, at relatively lower PHEY, because although Rwanda`s TTS is 
decent, it lags behind the EAC average, besides being attained at a comparatively higher PHEY.  
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Figure 6: Mean Improved Water Access and Mean Public Health Expenditures
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Figure 6 above illustrates that Rwanda on average had the second highest improved 
water access (IWA) in the East African Community region, supplemented by commensurately 
huge public health expenditure (PHEY).
Figure 7 below shows Rwanda`s reduction in HIV/AIDS prevalence (HIVPREV) 
plausibly occurred with a relatively large PHEY. It suffices to say that the effectiveness of public 
health expenditure in reducing HIV prevalence is also worthy of empirical investigation. 
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Figure 7: Mean HIV/AIDS Prevalence Rate and Mean Public Health Expenditures
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Figure 8 is also presented to show how infant mortality (INFMO) by and large reduces 
with increases in PHEY. This figure captures the five East African Community member-
countries for the period between 1995 and 2010.
Figure 8: Public Health Expenditures and Infant Mortality Rate
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Figure 9 furthermore shows that generally HIV/AIDS prevalence (HIVPREV) reduces 
with increases in public health expenditures (PHEY).
Figure 9: Public Health Expenditures and HIV/AIDS Prevalence Rate
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Next up, the bar graph supplements figures 4-7, shown as figures 10.
Figure 10: Public Health Expenditures as a share of GDP in the East African        
Community
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Figure 10 illustrates that Rwanda had the largest PHEY in the East African Community,
between 1995 and 2010. Basically, Rwanda had the lowest HIV/AIDS prevalence rate among its 
East African Community counter parts, though at proportionately high public health expenditures. 
However, its mean Infant Mortality Rate (INFMO) was second highest in the East African 
Community after Burundi`s, despite registering the highest mean high public health expenditures 
(PHEY) outlays. 
Noticeably too, Rwanda had the lowest mean life expectancy (LIFE), notwithstanding its 
highest mean PHEY in the East African Community. Besides, its Tuberculosis Treatment 
Success was also below the computed EAC average, notwithstanding its huge commitment of 
funds into the health sector. Therefore panel fixed effects regressions (Model 1 and 2) were run 
to ascertain the efficacy of public health expenditures in reducing the “Infant Mortality Rate”, 
and increasing “Life Expectancy”. Then implications are drawn to inform the policy 
prescriptions that Rwanda can adopt, in order to achieve the latter targeted health benefits. 
Indeed other than PHEY, other variables may significantly influence INFMO and LIFE. 
More so, Kenya and Tanzania were able to register rather high Tuberculosis Treatment Success 
(TTS) at significantly very low PHEYs, plausibly justifying studies on these countries 
experiences. Tables 4 and 5 show the regression models 1 and 2 mentioned in chapter 3.
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4.2. Regression Results on effectiveness of Public Health Expenditure in reducing Infant                            
Mortality and increasing Life Expectancy.
Table 4: Public Health Expenditures and Infant Mortality Rate
Infant Mortality Rate “Fixed Effects Model” “Fixed Effects Model” “Fixed Effects Model”
“Variables” (1) (2) (3)
Constant 47.809(4.23) 10.285(15.03) 10.563 (18.22)
LPHEY -0.050(-1.27) -0.053(-1.34) -0.080(-2.73)**
LFPI -0.110(-1.88) -0.149(-2.44)** -0.131(-2.33)**
LHIVPREV 0.065(1.13) 0.047(0.77)
LURB -0.720(-6.49)*** -0.555(-5.22)*** -0.594(-6.36)***
LISAF -10.960(-3.37)*** -0.204(-0.69) -0.219(-0.75)
LIWA -8.901(-3.22)*** 0.284(2.12) 0.024(2.04)
LCLEAN 2.755(3.32)***
LRYC -1.027(-8.02)*** -0.739(-7.31)*** -0.711(-7.57)***
LEDUC2 0.017(0.69) -0.008(0.32) -0.016(-0.67)
“R-square Within” 0.962 0.956 0.955
“R-square between” 0.969 0.832 0.800
“R-square overall” 0.641 0.824 0.818
                                                               Note: “*** reflects significance at 1%,” “** reflects significance at 5%”
                                                                 t- Statistics are reported in parenthesis
                                                 (1) Is equation 1 as described in chapter three.
                                                 (2) Is equation 1 excluding LCLEAN.
                                                 (3) Is equation 1 excluding LHIVPREV and LCLEAN.
 
While Novignon et al. (2012) found that health care expenditure both public and private 
reduce death and infant mortality rates, public heath care spending relatively having a higher 
impact, in this study, Table 4 model 1, LPHEY is also showing a negative relationship with 
LINFMO; but its coefficient does not reflect any statistical significance. LFPI is negatively 
related to LINFMO as well similar to initial expectation, but not statistically significant.                   
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LURB is negatively related to LINFMO as envisaged and statistically significant at 1% level. 
Although LISAF and LIWA are negatively related to LINFMO as envisaged and statistically 
significant at 1% level, their interaction term instead had a positive coefficient, and statistically 
significant at 1% level.  LRYC was negatively related to LINFMO, at a statistical significance 
level of 1%. LEDUC2 had a positive sign attached to its coefficient, but statistically insignificant. 
In the same table 4, the interaction term of LISAF and LIWA (LCLEAN) is excluded in 
model 2 to explain more the effectiveness of public health expenditure in reducing infant 
mortality rate. The results show that LPHEY is again negatively related to LINFMO but not 
statistically significant, LFPI is negatively related to LINFMO as expected and statistically 
significant at 5% level, akin to Kabir (2008). LHIVPREV has a positive sign attached to its 
coefficient as expected but without any statistical significance. LISAF shows a negative 
relationship with LINFMO as well, although lacking a statistical significance. LRYC shows also 
a negative relationship with LINFMO as anticipated and statistically significant at 1% level. 
LEDUC2 (female education) although is negatively related to LINFMO as expected nevertheless 
it is not statistically significant.
Finally in model 3, both LHIVPREV and LCLEAN are excluded from the analysis and 
the results show that LPHEY is negatively related to LINFMO as initially expected and 
statistically significant at 5% level, in concurrence with Novignon et al. (2012). LFPI is also 
negatively related to LINFMO as envisaged and statistically significant at 5% level, LURB 
exhibits a negative relation with LINFMO along with a statistical significance of 1% level. 
LISAF is negatively related to LINFMO but statistically insignificant. LRYC shows a negative 
relation to LINFMO with a statistical significance at 1% level. LEDUC2 (female education) 
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displays a negative relation to LINFMO but statistically insignificant. Table 5 seeks to explain 
the variation in life expectancy in the East African Community between the period 1995 and 
2010.
Table 5: Public Health Expenditures and Life Expectancy Rate
Life Expectancy Rate “Fixed effects model” “Fixed effects model”
“Variables”                (1)                  (2)
Constant 30.242 (6.52) 2.022(5.90)
LPHEY -0.027(-1.65) -0.019(-0.54)
LRYC 0.005(0.09) 0.296(3.86)***
LURB 0.586(12.87)***
LHIVPREV 0.011(0.45) -0.116(-2.86)***
LFPI 0.025(1.05) 0.099(2.09)**
LEDUC2 0.011(1.11)
LISAF -8.247(-6.19)***
LIWA -6.940(-6.11)***
LCLEAN 2.021(5.94)***
“R-square Within” 0.960 0.666
“R-square between” 0.193 0.632
“R-square overall” 0.290 0.606
Note: “*** Reflects significance at 1%,” “** reflects significance at 5%,” “* reflects significance at 10%.”
t- Statistics are reported in parenthesis
(1) Is equation 2 as described in chapter three
(2) Specified predictors without LURB
 
Note that Table 5 is consistent with the literature, by testing public health expenditures` 
impact, along with the variables controlled for, on the life expectancy rate (Kabir 2008).
In Table 5, LPHEY is negatively related to LIFE, which is contrary to theory, but statistically 
insignificant, akin to LRYC in Kabir (2008) `s study. However, LURB and LCLEAN are 
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positively related to LLIFE as expected, but LISAF and LIWA have negative coefficient signs, at 
a statistical significance of 1%, contrary to theory. 
Table 5 then has LURB, LEDUC2, LISAF, LIWA, and LCLEAN excluded from, as 
found statistically insignificant by other researchers (Kabir 2008). A shown in this table in model 
2 LPHEY is negatively related to LLIFE but statistically insignificant. LHIVPREV is negatively 
related to LLIFE as anticipated at a statistical significance of 1% level. LFPI has the expected 
positive coefficient, at a 5% level of statistical significance. LRYC is positively related to LLIFE 
as expected, at 1% level of statistical significance.
Akin to Kabir (2008), LPHEY was negatively related to LLIFE, and statistically 
insignificant. However, LHIVPREV showed a negative relation with LLIFE a long with a 
statistical significance of 1% level. Consumption of nutritious food, LFPI displayed a positive 
relation with LLIFE with a statistical significance of 5% level. Moreover, LRYC revealed   a 
positive relation with LLIFE coupled with a statistical significance of 1% level.
30 
 
CHAPTER FIVE: SAMMURY CONCLUSION AND POLICY IMPLICATIONS
5.1 Conclusion
This paper employed a standard panel fixed effects model to show how desired health 
benefits are determined by public spending on the health sector, between the period 1995 and 
2010, sampling five states of the East African Community, while taking into account the 
integration of Rwanda and Burundi in the East African Community in 2007. The study uniquely 
differs from other studies on Africa (or Sub-Saharan Africa) which basically referred to the East 
African Community as a three-member region, comprising only Kenya, Tanzania, and Uganda. 
With special emphasis on Rwanda`s health status, vis-à-vis the other four East African 
Community members, the study used mean variable ratios, relative to the East African 
Community`s strongest economy`s (Kenya) values to demonstrate the country`s performance. It 
is shown in the paper that Rwanda on average had a large infant mortality rate, second to 
Burundi, and higher than the computed East African Community average.
Another key finding of this paper was that the life expectancy rate in Rwanda was low, 
despite proportionately high public health expenditures.
5.2 Policy implications
The policy implication drawn from this study`s findings is that improving access to 
medical facilities and related infrastructure, proxied by urbanization, consumption of nutritious 
food, and reduction of HIV/AIDS prevalence rates, improving real per capita income, and 
broadening access to water and sanitation are key factors that the Rwandan Government may 
plausibly harness, in order to reduce the infant mortality rate. Mainly the latter factor may 
31 
 
require government intervention and oversight, in reference to the water and sewerage 
infrastructure, present in urban and peri-urban areas. 
Further studies, disintegrating the public health expenditures to tease out how funds 
directed to say medical research can reduce the incidence of diseases are recommended.                      
The Rwandan Government may render due attention to reducing HIV/AIDS prevalence, support 
programs for nutritious food consumption, coupled with improving real income per capita, 
coupled with increasing the accession to clean water and sanitation, if  life expectancy also raises 
a needs of being increased besides public health expenditures. 11Worth mentioning also, is that 
increasing access to pipe water may significantly reduce the number of hours and kilometers 
girls have to travel in order to fetch and carry water, hence affording them more time to focus on 
their education, by reducing tardiness and truancy, including increased time for their after-school 
assignments. This in turn has the potential to reduce the infant mortality rate. Moreover, 
government expenditures should place more emphasis on the expansion of water and sanitation 
expenditures since they are more effective in achieving the objective of health sector public 
expenditures.
In a nutshell, since public health expenditures were not effectively significant in creating 
desired health outcomes, the East African Community in general, and Rwanda in particular may 
have to structure and supplement their public health expenditures with donor funds, instituting 
strict monitoring and evaluation mechanisms, so that the funds achieve the desired health results, 
especially if related gains are to be sustained, and funds deficient health aspects are to be 
improved. 
                                                          
11 http://www.unicef.org/esaro/7310_Gender_and_WASH.html
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It suffices to say that healthy Rwandese, will not only live longer, but also ably ply their 
trades to ensure that economic development is attained. Precisely stated, public health 
expenditures alone can hardly suffice, to reduce say the infant mortality rate, or increase the life 
expectancy rate if other key factors are not taken into consideration by the Rwandan Government.
More study should be conducted on the structure of public health expenditures to 
indentify the reasons for their ineffectiveness. For example, the health expenditures should be 
disaggregate into tertiary health service expenditures, secondary health service expenditures, 
primary health service expenditures, R and D, etc. Indeed as an integral part of future studies on 
infant mortality rate and health expenditures, rigorous model specifications addressing
endogeneity issues should be employed, to better explain the variation in the former.
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 APPENDIX A
STATA Output for Table 4, Model (1): Public Health Expenditures and Infant Mortality 
Rate (EAC)
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 APPENDIX B
STATA Output for Table 4, Model (2): Public Health Expenditures and Infant Mortality 
Rate (EAC) excluding LCLEAN
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 APPENDIX C
STATA Output for Table 4, Model (3): Public Health Expenditures and Infant Mortality 
Rate (EAC) excluding both LCLEAN and HIVPREV 
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STATA Output for Table 5, Model (1): Public Health Expenditures and Life Expectancy 
(EAC)
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STATA Output for Table 5, Model (2): Public Health Expenditures, HIV/AIDS Prevalence, 
and Life Expectancy (EAC)
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